相关实验视频

Updated: Jun 22, 2026

Autologous Blood Injection to Model Spontaneous Intracerebral Hemorrhage in Mice

Autologous Blood Injection to Model Spontaneous Intracerebral Hemorrhage in Mice

Published on: August 24, 2011

抑制ADORA3可以加速血液瘤解脱和ICH后的神经恢复

Qi Yu¹, Xian Yu², Yirui Kuang²

¹Department of Nursing, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Cerebrovascular diseases (Basel, Switzerland)

|November 13, 2025

概括

使用MRS1523抑制腺素3受体 (ADORA3) 增强了脑出血后红细胞的微质清除. 这促进了神经系统的恢复,并减少了脑损伤和炎症.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

脑内出血 (ICH) 导致高死亡率和残疾.
微质介导的血瘤清除对于减少大脑损伤至关重要.
腺素3受体 (ADORA3) 在微质细胞和ICH中的作用尚不清楚.

研究的目的:

为了研究ADORA3在ICH后血液瘤解脱中的作用.
探索ADORA3在ICH后微质功能中的潜在机制.

主要方法:

使用自身血液注射建立了一个ICH小鼠模型.
小鼠接受了微质枯竭剂 (PLX3397) 和ADORA3抗剂 (MRS1523) 的治疗.
评估了神经行为功能,血瘤体积,血红蛋白含量和红细胞瘤. 还进行了免疫光,西部斑点,Nissl和TUNEL染色.

主要成果:

在ICH后,ADORA3表达增加,主要在微质细胞中.
MRS1523治疗改善了神经功能,减少了血瘤,并增强了微质红细胞形成.
抑制ADORA3降低了细胞受体表达 (AXL,MerTK),减少了神经元损伤/亡,并缓解了神经炎症.
耗尽微质细胞取消了MRS1523.3的保护作用.

结论:

抑制ADORA3通过促进红细胞的微质细胞化,加速了血液瘤的清除.
这种抑制减少了神经元损伤和围绕血液瘤的神经炎症.
用MRS1523准ADORA3,最终可以促进ICH后的神经恢复.

关键词:

亚多拉3是什么意思血液瘤的分辨率血液瘤的分辨率在这里,我找到了它.微质细胞中的微质细胞发细胞症 (phagocytosis) 是一种致死细胞的发生.

更多相关视频

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Published on: July 3, 2014

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation

Published on: June 10, 2020

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...